Nonablative 1,064-nm Nd:YAG Laser for Treating Atrophic Facial Acne Scars: Histologic and Clinical Analysis

Nonablative 1,064-nm Nd:YAG Laser for Treating Atrophic Facial Acne Scars: Histologic and Clinical Analysis
OnlineEarly Articles
To cite this article: RAQUEL KELLER MD, WALTER BELDA J?NIOR PHD, NEUSA YURIKO SAKAI VALENTE PHD, CONSUELO JUNQUEIRA RODRIGUES PHD
Nonablative 1,064-nm Nd:YAG Laser for Treating Atrophic Facial Acne Scars: Histologic and Clinical Analysis
Dermatologic Surgery (OnlineEarly Articles).
doi:10.1111/j.1524-4725.2007.33318.x
Blackwell Synergy

RAQUEL KELLER, MD*
*Department of Dermatology and , WALTER BELDA J?NIOR, PHD**Department of Dermatology and , NEUSA YURIKO SAKAI VALENTE, PHD**Department of Dermatology and , AND CONSUELO JUNQUEIRA RODRIGUES, PHDDepartment of Surgery, Universidade de SÑo Paulo, SÑo Paulo, Brazil

Address correspondence and reprint requests to: Raquel Keller, MD, Avenue. Ibirapuera, 2907, conj. 901-902, Moema, 04029-200 SÑo Paulo (SP), Brazil, or e-mail: raquelkl@uol.com.br
Raquel Keller, MD, Walter Belda J?nior, PhD, Neusa Yuriko Sakai Valente, PhD, and Consuelo Junqueira Rodrigues, PhD, have indicated no significant interest with commercial supporters.

Abstract
BACKGROUND Non-ablative methods have been attempted in treating atrophic facial scars, but the histologic findings do not always coincide with the clinical results and patient satisfaction.

OBJECTIVE To study the effects and safety of the Nd:YAG laser for treating atrophic facial scars.

MATERIAL AND METHODS Twelve subjects (skin phototypes II-V) with mild to moderate atrophic facial acne scars received five monthly treatments with 1,064 nm Nd:YAG laser and were photographed before, in the middle of, and 6 months after the last treatment. Histologic evaluations were performed on skin biopsies obtained before treatment and 1 month after the last session. Collagen quantification per area, before and after the treatment, was performed by morphometry, with computerized image analysis. Patient satisfaction and clinical condition were assessed using standard grading scales.

RESULTS Mild to moderate clinical improvement was observed in most patients. Photographic assessment of scars found visible cosmetic improvement in eleven patients. All patients were satisfied. There were statistically significant collagen increases in the dermis following the treatment. Side effects were limited to mild transient erythema and increased skin sensitivity after the procedure.

CONCLUSIONS The 1,064 nm Nd:YAG laser is a safe and effective nonablative method for improving atrophic scars, even in darker skin.

Blackwell Synergy? is a Blackwell Publishing, Inc. registered trademark

You can view the abstract online. A subscription is required to view the full text or it can be purchased online.